Toxicity Related to Standard TB Therapy for Pulmonary Tuberculosis and Treatment Outcomes in the REMoxTB Study According to HIV Status

BMC Pulmonary Medicine - United Kingdom
doi 10.1186/s12890-019-0907-6
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Toxicity Associated With Tuberculosis Chemotherapy in the REMoxTB Study

BMC Infectious Diseases
Infectious Diseases
2018English

Rifamycin Drugs as Alternatives to Standard Isoniazid Treatment to Prevent Active Tuberculosis (TB) in HIV-negative People at Risk of Developing Active TB

Clinical Epidemiology and Global Health
EpidemiologyPublic HealthMicrobiologyEnvironmentalInfectious DiseasesOccupational Health
2014English

TB Treatment Outcomes Among TB-HIV Co-Infections in Karnataka, India: How Do These Compare With Non-Hiv Tuberculosis Outcomes in the Province?

BMC Public Health
EnvironmentalPublic HealthOccupational Health
2013English

Diagnosis and Treatment Outcomes of Tuberculosis in Relation to Gender and HIV STATUS in South Benin

Journal of Tuberculosis Research
2017English

HIV Testing, HIV Status and Outcomes of Treatment for Tuberculosis in a Major Diagnosis and Treatment Centre in Yaounde, Cameroon: A Retrospective Cohort Study

BMC Infectious Diseases
Infectious Diseases
2012English

Preferential Adherence to Antiretroviral Therapy Over Tuberculosis Treatment: A Qualitative Study of Drug-Resistant TB/HIV Co-Infected Patients in South Africa

Global Public Health
EnvironmentalPublic HealthOccupational Health
2014English

Assessing the Impact of TB/HIV Services Integration on TB Treatment Outcomes and Their Relevance in TB/HIV Monitoring in Ghana

Infectious Diseases of Poverty
MedicineEnvironmentalPublic HealthInfectious DiseasesOccupational Health
2012English

Treatment Outcomes of Smear Positive Pulmonary TB Cases Registered in TB Patients in Quetta

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2015English

Standard Antifungal Therapy for Pulmonary Cryptococcosis to Improve Prognosis

The Lancet Infectious Diseases
Infectious Diseases
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy